4//SEC Filing
Slager David Mark 4
Accession 0001213900-17-008982
CIK 0001176309other
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 1:56 PM ET
Size
8.3 KB
Accession
0001213900-17-008982
Insider Transaction Report
Form 4
Slager David Mark
10% Owner
Transactions
- Exercise/Conversion
Warrant (right to buy)
2017-08-17$1.18/sh−112,613$132,838→ 0 total(indirect: By Regals Fund LP)Exercise: $3.77From: 2012-08-28Exp: 2017-08-28→ Common Stock (112,613 underlying) - Exercise/Conversion
Common Stock
2017-08-17$3.77/sh+112,613$424,056→ 1,299,436 total(indirect: By Regals Fund LP)
Footnotes (3)
- [F1]Mr. Slager is Managing Member of the general partner of Regals Capital Management LP ("Regals Management"). Regals Management is the investment manager of Regals Fund LP (the "Fund"). The securities reported herein are held for the account of the Fund. Pursuant to Rule 16a-1(a)(4) under the Act, Mr. Slager disclaims beneficial ownership in the securities owned by the Fund except to the extent, if any, of his pecuniary interest therein.
- [F2]The number of shares underlying such warrant and the applicable exercise price reflect a one-for-twelve reverse stock split effected by the issuer on January 22, 2013.
- [F3]The shares and warrants were purchased as "units" at a price per unit of $4.44 in connection with the Issuer's 2012 private placement. The consideration was allocated to the shares and warrants based on relative fair value. The value allocated to the warrants was estimated by using the Black Scholes option-pricing model.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001477733
Filing Metadata
- Form type
- 4
- Filed
- Aug 20, 8:00 PM ET
- Accepted
- Aug 21, 1:56 PM ET
- Size
- 8.3 KB